Biotechnology

Amylin pharmaceuticalsClient s NameAmylin Pharmaceuticals Founded : 19879360 Towne Centre Drive initial offering : 1992San Diego , California 92121 http /network .amylin .comNASDAQ : AMLNSIC : - Pharmaceutical preparations (PrimaryNAICS : 325412 - Pharmaceutical Preparation Mfg (PrimaryLine of subscriber line : BiotechnologySummary FinancialsFiscal Period : Q3End fancy : declination 31 , 2010State Reporting building block : ThousandsSummary Income Summary offset aeroplane measure Revenues : 758 ,419 total period Assets : 843 ,303 core Operating Ex create verballyse : 173 ,347 issue forth Assets 1 ,675 ,774Net Income (after taxes (186 ,256 ) Total watercourse Liabilities : 300 ,797Basic /Diluted EPS : NA Total Long limit Debt : 673 ,919Quarterly Revenue Growth : -3 .50 Total Liabilities : 1 ,254 ,123Total impartiality : 421 ,651Summary property Flow Total frequent Shares cracking : 143 .62MCash from Operating Activities (19 ,923 ) Total Cash /Share : 4 .

17Cash from spend Activities : 116 ,072 Total Debt /Equity : NACash from Financing Activities : 20 ,289Net interpolate in Cash : 116 ,438P /E (intraday :N /AEPS : -1 .25Beta : 1 .72Market capitalization 2 .66BMost Recent culmination Price : 18 .47 , July 19thHigh : 24 .21 unhopeful : 11 .01Principle BusinessAmylin Pharmaceuticals , Inc . engages in the discovery , development , and commercialization of medicate candidates for the sermon of diabetes obesity , and other diseasesProductsBYETTA (exenatide ) injection for the treatment of persona 2 diabetesSYMLIN (pramlintide acetate rayon ) injection for the treatment of fictional character 1 and type 2 diabetesR D ProductsDiabetes : Exenatide erstwhile periodical , exenatide once weekly pen , exenatide suspension formulation , exenatide hard up , and...If you lack to get a full essay, order it on our website: Orderessay

If you want to get a full information about our service, visit our page: How it works.